Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 21 | 2020 | 307 | 5.020 |
Why?
|
| Automobile Driving | 13 | 2018 | 88 | 3.260 |
Why?
|
| Self-Injurious Behavior | 3 | 2022 | 31 | 1.660 |
Why?
|
| Interior Design and Furnishings | 6 | 2017 | 11 | 1.370 |
Why?
|
| Limbic System | 4 | 2010 | 106 | 1.330 |
Why?
|
| Psychomotor Performance | 4 | 2017 | 213 | 1.190 |
Why?
|
| Computer Simulation | 5 | 2016 | 706 | 1.080 |
Why?
|
| Brain Diseases, Metabolic | 3 | 2010 | 9 | 1.020 |
Why?
|
| Suicide, Attempted | 4 | 2022 | 72 | 0.970 |
Why?
|
| Automobiles | 3 | 2014 | 26 | 0.950 |
Why?
|
| Positron-Emission Tomography | 7 | 2014 | 160 | 0.900 |
Why?
|
| Prefrontal Cortex | 6 | 2020 | 640 | 0.890 |
Why?
|
| Hospitalization | 5 | 2022 | 978 | 0.890 |
Why?
|
| Visual Perception | 2 | 2017 | 124 | 0.870 |
Why?
|
| Antipsychotic Agents | 7 | 2011 | 247 | 0.850 |
Why?
|
| Patient Readmission | 3 | 2021 | 267 | 0.770 |
Why?
|
| Supervised Machine Learning | 1 | 2021 | 4 | 0.760 |
Why?
|
| Women | 1 | 2021 | 40 | 0.740 |
Why?
|
| Patients' Rooms | 3 | 2015 | 15 | 0.730 |
Why?
|
| Reaction Time | 4 | 2017 | 170 | 0.720 |
Why?
|
| Middle Aged | 33 | 2022 | 21147 | 0.700 |
Why?
|
| Rehabilitation Centers | 3 | 2015 | 46 | 0.690 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 106 | 0.670 |
Why?
|
| Mental Disorders | 2 | 2022 | 659 | 0.650 |
Why?
|
| Humans | 57 | 2022 | 68618 | 0.620 |
Why?
|
| Female | 40 | 2022 | 38074 | 0.620 |
Why?
|
| Mental Recall | 3 | 2009 | 72 | 0.610 |
Why?
|
| Male | 42 | 2022 | 37321 | 0.610 |
Why?
|
| Citalopram | 2 | 2015 | 30 | 0.600 |
Why?
|
| Cerebral Cortex | 3 | 2010 | 415 | 0.600 |
Why?
|
| Adult | 28 | 2021 | 21403 | 0.590 |
Why?
|
| Hospitals, Psychiatric | 2 | 2009 | 59 | 0.590 |
Why?
|
| Young Adult | 15 | 2021 | 5717 | 0.590 |
Why?
|
| Neuropsychological Tests | 4 | 2014 | 517 | 0.570 |
Why?
|
| Attention | 3 | 2010 | 225 | 0.570 |
Why?
|
| Aged | 21 | 2021 | 14862 | 0.570 |
Why?
|
| Psychotic Disorders | 3 | 2022 | 157 | 0.560 |
Why?
|
| Motor Skills | 1 | 2016 | 88 | 0.530 |
Why?
|
| Affect | 3 | 2014 | 218 | 0.520 |
Why?
|
| Depressive Disorder, Major | 3 | 2015 | 439 | 0.500 |
Why?
|
| Hand | 2 | 2014 | 90 | 0.490 |
Why?
|
| Fluorodeoxyglucose F18 | 6 | 2010 | 81 | 0.480 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 111 | 0.470 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2014 | 5 | 0.470 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2014 | 2223 | 0.470 |
Why?
|
| Vision, Ocular | 1 | 2014 | 68 | 0.470 |
Why?
|
| Functional Neuroimaging | 1 | 2014 | 82 | 0.460 |
Why?
|
| Depression | 5 | 2021 | 943 | 0.450 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 149 | 0.440 |
Why?
|
| Movement | 1 | 2014 | 179 | 0.440 |
Why?
|
| Occupational Therapy | 1 | 2014 | 80 | 0.440 |
Why?
|
| Inpatients | 1 | 2015 | 208 | 0.440 |
Why?
|
| Brain Mapping | 3 | 2011 | 532 | 0.430 |
Why?
|
| Rest | 2 | 2009 | 78 | 0.420 |
Why?
|
| Benzodiazepines | 2 | 2012 | 130 | 0.420 |
Why?
|
| Risk Factors | 10 | 2022 | 5731 | 0.390 |
Why?
|
| Verbal Learning | 3 | 2009 | 29 | 0.380 |
Why?
|
| Sensory Deprivation | 1 | 2010 | 5 | 0.380 |
Why?
|
| Weather | 1 | 2010 | 9 | 0.380 |
Why?
|
| Acceleration | 1 | 2010 | 37 | 0.370 |
Why?
|
| Biomarkers | 2 | 2014 | 1593 | 0.370 |
Why?
|
| Brain | 3 | 2011 | 2176 | 0.370 |
Why?
|
| Central Nervous System Depressants | 1 | 2012 | 182 | 0.370 |
Why?
|
| Motion Sickness | 1 | 2010 | 6 | 0.360 |
Why?
|
| Choice Behavior | 1 | 2010 | 85 | 0.360 |
Why?
|
| Light | 2 | 2014 | 152 | 0.350 |
Why?
|
| Accidents, Traffic | 4 | 2012 | 109 | 0.350 |
Why?
|
| Adolescent | 10 | 2022 | 8912 | 0.330 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2009 | 23 | 0.330 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2013 | 782 | 0.330 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 435 | 0.330 |
Why?
|
| Outpatients | 2 | 2010 | 127 | 0.320 |
Why?
|
| Radiopharmaceuticals | 4 | 2009 | 114 | 0.300 |
Why?
|
| Dementia | 2 | 2006 | 158 | 0.300 |
Why?
|
| Cognition | 2 | 2008 | 513 | 0.290 |
Why?
|
| Walking | 3 | 2012 | 241 | 0.290 |
Why?
|
| Temporal Lobe | 1 | 2008 | 125 | 0.290 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 191 | 0.280 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 319 | 0.270 |
Why?
|
| Aged, 80 and over | 7 | 2015 | 4848 | 0.270 |
Why?
|
| Clarithromycin | 1 | 2005 | 11 | 0.270 |
Why?
|
| Ethanol | 1 | 2012 | 893 | 0.260 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2005 | 20 | 0.260 |
Why?
|
| Cyclothymic Disorder | 2 | 2020 | 2 | 0.260 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 147 | 0.260 |
Why?
|
| Visual Fields | 1 | 2005 | 41 | 0.260 |
Why?
|
| Contrast Sensitivity | 1 | 2005 | 28 | 0.250 |
Why?
|
| Algorithms | 3 | 2021 | 1196 | 0.250 |
Why?
|
| Amygdala | 2 | 2020 | 159 | 0.250 |
Why?
|
| Awareness | 2 | 2012 | 81 | 0.250 |
Why?
|
| Plants, Medicinal | 1 | 2005 | 43 | 0.250 |
Why?
|
| Phytotherapy | 1 | 2005 | 53 | 0.240 |
Why?
|
| Vision Disorders | 1 | 2005 | 94 | 0.240 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1054 | 0.230 |
Why?
|
| Health Status | 1 | 2006 | 429 | 0.220 |
Why?
|
| Health Personnel | 2 | 2018 | 286 | 0.210 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2077 | 0.210 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 561 | 0.210 |
Why?
|
| Aging | 5 | 2011 | 911 | 0.200 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 1242 | 0.200 |
Why?
|
| Case-Control Studies | 4 | 2010 | 1553 | 0.200 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 371 | 0.200 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 940 | 0.190 |
Why?
|
| Health Education | 1 | 2004 | 279 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 2279 | 0.190 |
Why?
|
| Interleukin-8 | 1 | 2021 | 71 | 0.190 |
Why?
|
| Dibenzothiazepines | 2 | 2012 | 15 | 0.190 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2021 | 29 | 0.190 |
Why?
|
| Comorbidity | 3 | 2019 | 1426 | 0.190 |
Why?
|
| Cohort Studies | 2 | 2021 | 2358 | 0.180 |
Why?
|
| Self-Help Devices | 2 | 2017 | 14 | 0.180 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 78 | 0.180 |
Why?
|
| Analysis of Variance | 3 | 2015 | 1040 | 0.170 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 216 | 0.170 |
Why?
|
| Ergonomics | 2 | 2017 | 40 | 0.170 |
Why?
|
| Decision Trees | 1 | 2019 | 74 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 1026 | 0.160 |
Why?
|
| Robotics | 2 | 2017 | 56 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1753 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2014 | 7029 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 333 | 0.150 |
Why?
|
| Brain Concussion | 1 | 2018 | 27 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2021 | 7277 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 170 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2009 | 689 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2021 | 374 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 767 | 0.140 |
Why?
|
| Splints | 1 | 2016 | 10 | 0.140 |
Why?
|
| Immobilization | 1 | 2016 | 26 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2012 | 649 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.130 |
Why?
|
| Age Factors | 4 | 2014 | 1864 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2019 | 448 | 0.130 |
Why?
|
| Upper Extremity | 1 | 2016 | 112 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2017 | 230 | 0.130 |
Why?
|
| Education, Special | 1 | 2014 | 5 | 0.120 |
Why?
|
| Psychotropic Drugs | 2 | 2012 | 83 | 0.120 |
Why?
|
| Length of Stay | 2 | 2009 | 780 | 0.120 |
Why?
|
| Posture | 2 | 2014 | 107 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 150 | 0.110 |
Why?
|
| Time Factors | 4 | 2012 | 4655 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2014 | 94 | 0.110 |
Why?
|
| United States | 4 | 2011 | 7367 | 0.110 |
Why?
|
| Stroke Rehabilitation | 1 | 2017 | 335 | 0.100 |
Why?
|
| Chemoprevention | 1 | 2012 | 26 | 0.100 |
Why?
|
| Night Vision | 1 | 2012 | 2 | 0.100 |
Why?
|
| Form Perception | 2 | 2012 | 16 | 0.100 |
Why?
|
| Prognosis | 2 | 2014 | 2093 | 0.100 |
Why?
|
| Rehabilitation | 1 | 2012 | 29 | 0.100 |
Why?
|
| Functional Laterality | 2 | 2010 | 240 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 106 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2012 | 172 | 0.100 |
Why?
|
| Triazines | 1 | 2012 | 48 | 0.100 |
Why?
|
| Safety | 1 | 2012 | 145 | 0.100 |
Why?
|
| Assisted Living Facilities | 1 | 2011 | 3 | 0.100 |
Why?
|
| Distance Perception | 1 | 2010 | 3 | 0.090 |
Why?
|
| Kinesthesis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Delirium | 1 | 2011 | 45 | 0.090 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 48 | 0.090 |
Why?
|
| Orientation | 1 | 2010 | 31 | 0.090 |
Why?
|
| Gyrus Cinguli | 2 | 2009 | 113 | 0.090 |
Why?
|
| Utilization Review | 1 | 2010 | 48 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 658 | 0.090 |
Why?
|
| Eye Movements | 1 | 2010 | 44 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2010 | 89 | 0.090 |
Why?
|
| Health Services | 1 | 2010 | 87 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2010 | 219 | 0.080 |
Why?
|
| Risk-Taking | 1 | 2010 | 210 | 0.080 |
Why?
|
| Protective Clothing | 2 | 2012 | 12 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 31 | 0.080 |
Why?
|
| Antimanic Agents | 1 | 2009 | 21 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 148 | 0.080 |
Why?
|
| Metformin | 1 | 2009 | 63 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2009 | 86 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2008 | 45 | 0.080 |
Why?
|
| Motion Perception | 1 | 2008 | 8 | 0.080 |
Why?
|
| Weight Gain | 1 | 2009 | 135 | 0.080 |
Why?
|
| Visual Acuity | 2 | 2008 | 236 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2010 | 324 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 1851 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 342 | 0.070 |
Why?
|
| Sleep Wake Disorders | 1 | 2008 | 94 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2009 | 206 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2009 | 223 | 0.070 |
Why?
|
| Life Style | 1 | 2009 | 338 | 0.070 |
Why?
|
| Glucose | 1 | 2008 | 307 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 951 | 0.070 |
Why?
|
| Signal Detection, Psychological | 3 | 2013 | 21 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2006 | 49 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 1420 | 0.070 |
Why?
|
| Sleep | 1 | 2008 | 263 | 0.070 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2006 | 151 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 362 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2009 | 622 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2012 | 2800 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2008 | 419 | 0.060 |
Why?
|
| Herb-Drug Interactions | 1 | 2005 | 5 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2005 | 71 | 0.060 |
Why?
|
| Hypericum | 1 | 2005 | 6 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2012 | 3705 | 0.060 |
Why?
|
| ROC Curve | 3 | 2013 | 392 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 135 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2006 | 199 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2005 | 206 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2011 | 1615 | 0.060 |
Why?
|
| Word Association Tests | 1 | 2003 | 1 | 0.060 |
Why?
|
| Mental Processes | 1 | 2003 | 22 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2003 | 69 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2009 | 2007 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 1140 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 410 | 0.050 |
Why?
|
| Physicians | 1 | 2005 | 324 | 0.050 |
Why?
|
| Quetiapine Fumarate | 2 | 2012 | 20 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 565 | 0.050 |
Why?
|
| Equipment Design | 2 | 2014 | 500 | 0.050 |
Why?
|
| Smoking | 1 | 2008 | 1452 | 0.040 |
Why?
|
| Quality of Life | 1 | 2008 | 1515 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 426 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 955 | 0.040 |
Why?
|
| South Carolina | 1 | 2004 | 2752 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 260 | 0.030 |
Why?
|
| Nigeria | 1 | 2014 | 35 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 62 | 0.030 |
Why?
|
| Hand Strength | 1 | 2014 | 47 | 0.030 |
Why?
|
| Workflow | 1 | 2014 | 100 | 0.030 |
Why?
|
| Remission Induction | 1 | 2013 | 111 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2014 | 392 | 0.030 |
Why?
|
| Patient Preference | 1 | 2013 | 57 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 369 | 0.030 |
Why?
|
| Color | 1 | 2012 | 50 | 0.030 |
Why?
|
| Transportation | 1 | 2012 | 21 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 242 | 0.020 |
Why?
|
| Hematocrit | 1 | 2011 | 70 | 0.020 |
Why?
|
| Morphine | 1 | 2011 | 76 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2011 | 27 | 0.020 |
Why?
|
| Universities | 1 | 2012 | 191 | 0.020 |
Why?
|
| Hospitals | 1 | 2013 | 265 | 0.020 |
Why?
|
| Students | 1 | 2012 | 233 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 186 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 257 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2009 | 59 | 0.020 |
Why?
|
| Reading | 1 | 2008 | 19 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 567 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2008 | 27 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 931 | 0.020 |
Why?
|
| Intelligence | 1 | 2008 | 45 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2009 | 119 | 0.020 |
Why?
|
| California | 1 | 2008 | 99 | 0.020 |
Why?
|
| Age of Onset | 1 | 2008 | 188 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2012 | 413 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 1738 | 0.020 |
Why?
|
| Memory | 1 | 2008 | 214 | 0.020 |
Why?
|
| Association Learning | 1 | 2006 | 36 | 0.020 |
Why?
|
| Imagination | 1 | 2006 | 38 | 0.020 |
Why?
|
| Face | 1 | 2006 | 46 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1745 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 498 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2006 | 79 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 69 | 0.020 |
Why?
|
| Decision Making, Organizational | 1 | 2005 | 23 | 0.020 |
Why?
|
| Judgment | 1 | 2005 | 40 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 579 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 201 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3259 | 0.010 |
Why?
|
| Veterans | 1 | 2005 | 904 | 0.010 |
Why?
|